| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Belite Bio, Inc | $157.69 | 2.4% | $6.32B | -68.3 | -78.4% | — | Healthcare | 169% | — | ||
| 2 | Opus Genetics, Inc. | $4.05 | -0.5% | $3.52B | -5.1 | 32.5% | — | Healthcare | 308.2% | -12.2% | ||
| 3 | Tarsus Pharmaceuticals, Inc. | $60.89 | -3.3% | $2.62B | -38.3 | 58.2% | — | Healthcare | 52.5% | 129% | ||
| 4 | Ocular Therapeutix, Inc. | $10.33 | 6.9% | $2.26B | -7.3 | -27% | — | Healthcare | 7.5% | -12.8% | ||
| 5 | Kodiak Sciences Inc. | $38.30 | 3.5% | $2.03B | -8.9 | -14.9% | — | Healthcare | 932.3% | — | ||
| 6 | Viridian Therapeutics, Inc. | $20.47 | 7.8% | $1.74B | -6.2 | 9.6% | — | Healthcare | 28.8% | 23382.8% | ||
| 7 | EyePoint Pharmaceuticals, Inc. | $14.02 | -2.9% | $1.17B | -4.4 | -45.2% | — | Healthcare | 47.7% | -86.4% | ||
| 8 | Oculis Holding AG | $13.56 | -1.7% | $775M | -6.0 | 27% | — | Healthcare | -27.6% | — | ||
| 9 | LENZ Therapeutics, Inc. | $5.90 | 5.4% | $185M | -2.1 | -103.4% | — | Healthcare | -81.3% | — | ||
| 10 | Aldeyra Therapeutics, Inc. | $2.23 | -2.2% | $135M | -4.0 | 52.9% | — | Healthcare | -48.7% | — | ||
| 11 | OKYO Pharma Limited | $1.75 | 8.7% | $67M | -14.6 | 47.6% | — | Healthcare | -37.9% | — | ||
| 12 | Outlook Therapeutics, Inc. | $1.46 | 2.8% | $60M | -0.8 | -10.6% | — | Healthcare | -21.5% | 95.8% | ||
| 13 | KALA BIO, Inc. | $1.51 | -1.9% | $33M | -0.5 | 64.9% | — | Healthcare | -99.4% | — | ||
| 14 | Skye Bioscience, Inc. | $0.70 | 0% | $25M | -0.5 | -75.6% | — | Healthcare | -84% | — | ||
| 15 | Kiora Pharmaceuticals, Inc. | $2.55 | 0% | $11M | -1.0 | 17.3% | — | Healthcare | -9.3% | — | ||
| 16 | NovaBay Pharmaceuticals, Inc. | $1.47 | -21.8% | $9M | -0.6 | 101.1% | — | Healthcare | -55.6% | -74.7% | ||
| 17 | Clearside Biomedical, Inc. | $0.41 | 0% | $2M | -0.1 | 23.9% | — | Healthcare | -96.6% | -56.8% |